Strong H1, AUM growth continues post-results
We knew momentum was strong on an absolute basis in H1 22 with AUM reaching £23.4bn on 30 Sep 21,...
Read moreTrading update on progress across all divisions
BEG’s trading update confirmed a strong first half as all areas of the business benefit from recent...
Read moreImpressive interims support recent upgrade
In October, we upgraded our forecasts and fair value based on higher-than-expected AUM at the end...
Read moreFurther long-term value creation
Planning approval has been granted for the second phase of the Marleigh development, comprising 421...
Read moreSupport on both fronts
Destiny’s most recently acquired Phase 3-ready product, the non-toxigenic Clostridioides difficile...
Read moreSignificant milestone and trading update
RUA Life Sciences released a well-received announcement on an important milestone in the...
Read moreBuoyant jobs market, bullish outlook
UK employers are scrambling to backfill 1.1m positions displaced by the pandemic, amidst a...
Read moreBrand strength underpins strong growth outlook
UPGS’s combination of strong brands, targeted distribution channels and demonstrable success in M&A...
Read more$17m contract win for production inspection systems
Kromek announced today that it had been awarded a 7 year $17m contract with a large US OEM to...
Read more